These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

651 related articles for article (PubMed ID: 6365739)

  • 21. Detection of deletions spanning the Duchenne muscular dystrophy locus using a tightly linked DNA segment.
    Monaco AP; Bertelson CJ; Middlesworth W; Colletti CA; Aldridge J; Fischbeck KH; Bartlett R; Pericak-Vance MA; Roses AD; Kunkel LM
    Nature; 1985 Aug 29-Sep 4; 316(6031):842-5. PubMed ID: 2993910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carrier detection in Becker muscular dystrophy using creatine kinase estimation and DNA analysis.
    Kingston HM; Sarfarazi M; Newcombe RG; Willis N; Harper PS
    Clin Genet; 1985 Apr; 27(4):383-91. PubMed ID: 3995787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Manifesting carrier of x-linked Duchenne muscular dystrophy.
    Meola G; Scarpini E; Silani V; Scarlato G
    J Neurol Sci; 1981 Mar; 49(3):455-63. PubMed ID: 7217994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular genetics and genetic counselling for Duchenne/Becker muscular dystrophy.
    Laing NG
    Mol Cell Biol Hum Dis Ser; 1993; 3():37-84. PubMed ID: 8111545
    [No Abstract]   [Full Text] [Related]  

  • 25. Estimate of the intrafamilial correlation for serum creatine kinase and pyruvate kinase in females at risk for Duchenne and Becker muscular dystrophies.
    Rabbi-Bortolini E; Dal Colletto GM; Passos-Bueno MR; Vainzof M; Rapaport D; Zatz M
    Hum Hered; 1991; 41(6):370-8. PubMed ID: 1797630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estimates of conditional heterozygosity risks for young females in Duchenne muscular dystrophy.
    Passos-Bueno MR; Otto PA; Zata M
    Hum Hered; 1989; 39(4):202-11. PubMed ID: 2583732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An isolated case of Duchenne muscular dystrophy (DMD) in a female with a deletion of DMD cDNA.
    Yoshioka M; Yamamoto Y; Furuyama J
    Clin Genet; 1990 Dec; 38(6):474-8. PubMed ID: 2289321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of dystrophin genomic and cDNA probes for solving difficulties in carrier detection and prenatal diagnosis of Duchenne muscular dystrophy.
    Shomrat R; Driks N; Legum C; Shiloh Y
    Am J Med Genet; 1992 Feb; 42(3):281-7. PubMed ID: 1536162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Italian experience regarding the prevention of Duchenne and Becker muscular dystrophies.
    Romeo G; Devoto M; Archidiacono N; Ferlini A; Roncuzzi L; Melis MA; Paderi E; Ferrari M; Tedeschi S; Galluzzi G
    Eur J Pediatr; 1988 May; 147(4):412-5. PubMed ID: 3165066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis of DMD carrier status in a family with no known affected males.
    Muntoni F; Mateddu A; Cau M; Congiu R; Puddu R; Cossu P; Cao A; Melis MA
    Dev Med Child Neurol; 1993 Jan; 35(1):70-3. PubMed ID: 8095479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum pyruvate-kinase (PK) and creatine-phosphokinase (CPK) in female relatives and patients with X-linked muscular dystrophies (Duchenne and Becker).
    Zatz M; Shapiro LJ; Campion DS; Kaback MM; Otto PA
    J Neurol Sci; 1980 Jun; 46(3):267-79. PubMed ID: 7381516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular biological approaches to genetic disorders in prenatal diagnosis.
    Katayama S
    Early Hum Dev; 1992; 29(1-3):149-53. PubMed ID: 1356752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Germline mosaicism and Duchenne muscular dystrophy mutations.
    Bakker E; Van Broeckhoven C; Bonten EJ; van de Vooren MJ; Veenema H; Van Hul W; Van Ommen GJ; Vandenberghe A; Pearson PL
    Nature; 1987 Oct 8-14; 329(6139):554-6. PubMed ID: 2889144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Direct method for prenatal diagnosis and carrier detection in Duchenne/Becker muscular dystrophy using the entire dystrophin cDNA.
    Darras BT; Koenig M; Kunkel LM; Francke U
    Am J Med Genet; 1988 Mar; 29(3):713-26. PubMed ID: 2897793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The value of deletion analysis for carrier detection in Duchenne muscular dystrophy (DMD).
    Bejjani B; Finn P; Milunsky A; Amos J
    Clin Genet; 1991 Apr; 39(4):245-52. PubMed ID: 2070545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The diagnostic value of plasma myoglobin levels in the adult and fetus at-risk for Duchenne muscular dystrophy.
    Edwards RJ; Rodeck CH; Watts DC
    J Neurol Sci; 1984 Feb; 63(2):173-82. PubMed ID: 6707690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Somatic mosaicism at the Duchenne locus.
    Lebo RV; Olney RK; Golbus MS
    Am J Med Genet; 1990 Oct; 37(2):187-90. PubMed ID: 1978985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Population data on benign and severe forms of X-linked muscular dystrophy.
    Mostacciuolo ML; Lombardi A; Cambissa V; Danieli GA; Angelini C
    Hum Genet; 1987 Mar; 75(3):217-20. PubMed ID: 3557448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic counseling in Becker type X-linked muscular dystrophy. II: Practical considerations.
    Grimm T
    Am J Med Genet; 1984 Aug; 18(4):719-23. PubMed ID: 6486170
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased chloride efflux in fibroblasts from X-linked muscular dystrophies and clones from Duchenne carriers.
    Rugolo M; Rocchi M; Lenaz G; Romeo G
    FEBS Lett; 1987 Feb; 212(2):313-6. PubMed ID: 3817163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.